The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 164.60
Bid: 164.00
Ask: 164.60
Change: 1.00 (0.61%)
Spread: 0.60 (0.366%)
Open: 163.60
High: 164.80
Low: 163.00
Prev. Close: 163.60
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Templeton Emerging Markets

14 Jan 2022 09:33

RNS Number : 4905Y
Templeton Emerging Markets IT PLC
14 January 2022
 

 

London, UK, 14 January 2022

 

Edison issues review on Templeton Emerging Markets Investment Trust (TEM)

Templeton Emerging Markets Investment Trust (TEMIT) is by far the largest fund in the AIC Global Emerging Markets sector. Its two managers Chetan Sehgal (lead manager) and Andrew Ness seek companies with robust business models, sustainable earnings growth potential and which are trading at a discount to their estimated intrinsic values. The managers' considerable experience, coupled with the deep resources of a broad investment team, enables them to identify interesting opportunities that may be overlooked by other investors. While TEMIT's performance has been disappointing over the last 12 months, partly due to a tighter Chinese regulatory environment, the trust has outpaced the performance of the MSCI Emerging Markets Index over the last three and five years.

In July 2021 there was a 5:1 share split with the objective of facilitating smaller investments and the reinvestment of dividends. TEMIT is currently trading at a 9.4% discount to cum-income NAV, which is within the range of 8.9% to 11.2% average discounts over the last one, three, five and 10 years. Dividends are paid semi-annually in January and July and the trust's current yield is 2.1%. TEMIT is subject to a five-year continuation vote; the next is due in July 2024.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Victoria Chernykh +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEANFLFDFAEEA
Date   Source Headline
23rd Feb 20245:02 pmRNSTransaction in Own Shares
23rd Feb 20249:06 amRNSNet Asset Value(s)
22nd Feb 20244:53 pmRNSTransaction in Own Shares
22nd Feb 20249:07 amRNSNet Asset Value(s)
21st Feb 20244:53 pmRNSTransaction in Own Shares
21st Feb 20248:52 amRNSNet Asset Value(s)
20th Feb 20245:00 pmRNSTransaction in Own Shares
20th Feb 20249:27 amRNSPortfolio Update
20th Feb 20249:02 amRNSNet Asset Value(s)
19th Feb 20244:57 pmRNSTransaction in Own Shares
19th Feb 20248:39 amRNSNet Asset Value(s)
16th Feb 20248:38 amRNSNet Asset Value(s)
15th Feb 20248:39 amRNSNet Asset Value(s)
14th Feb 20249:14 amRNSNet Asset Value(s)
9th Feb 20245:02 pmRNSTransaction in Own Shares
9th Feb 20248:31 amRNSNet Asset Value(s)
8th Feb 20248:50 amRNSNet Asset Value(s)
7th Feb 20244:58 pmRNSTransaction in Own Shares
7th Feb 20248:41 amRNSNet Asset Value(s)
6th Feb 20249:05 amRNSNet Asset Value(s)
5th Feb 20249:01 amRNSNet Asset Value(s)
2nd Feb 20244:57 pmRNSTransaction in Own Shares
2nd Feb 20248:41 amRNSNet Asset Value(s)
1st Feb 202410:25 amRNSNet Asset Value(s)
1st Feb 20249:18 amRNSTotal Voting Rights
31st Jan 20248:54 amRNSNet Asset Value(s)
30th Jan 20249:28 amRNSUpdate on debt facility
30th Jan 20249:24 amRNSNet Asset Value(s)
30th Jan 20249:22 amRNSChange of director details
29th Jan 20245:05 pmRNSTransaction in Own Shares
29th Jan 20249:08 amRNSNet Asset Value(s)
26th Jan 20248:39 amRNSNet Asset Value(s)
25th Jan 20248:53 amRNSNet Asset Value(s)
24th Jan 20248:44 amRNSNet Asset Value(s)
23rd Jan 20248:44 amRNSNet Asset Value(s)
22nd Jan 20248:51 amRNSNet Asset Value(s)
22nd Jan 20248:25 amRNSPortfolio Update
19th Jan 20249:09 amRNSNet Asset Value(s)
18th Jan 20249:18 amRNSNet Asset Value(s)
17th Jan 20249:25 amRNSNet Asset Value(s)
16th Jan 20249:47 amRNSNet Asset Value(s)
15th Jan 20249:00 amRNSNet Asset Value(s)
12th Jan 20249:44 amRNSNet Asset Value(s)
11th Jan 20249:14 amRNSNet Asset Value(s)
10th Jan 20249:32 amRNSNet Asset Value(s)
9th Jan 20249:21 amRNSNet Asset Value(s)
8th Jan 20249:35 amRNSNet Asset Value(s)
5th Jan 20249:24 amRNSNet Asset Value(s)
4th Jan 20249:24 amRNSNet Asset Value(s)
3rd Jan 20249:33 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.